The diseasome of physical inactivity – and the role of myokines in muscle–fat cross talk

Type 2 diabetes, cardiovascular diseases, colon cancer, breast cancer, dementia and depression constitute a cluster of diseases, which defines ‘a diseasome of physical inactivity’. Both physical inactivity and abdominal adiposity, reflecting accumulation of visceral fat mass, are associated with the occurrence of the diseases within the diseasome. Physical inactivity appears to be an independent and strong risk factor for accumulation of visceral fat, which again is a source of systemic inflammation. Chronic inflammation is involved in the pathogenesis of insulin resistance, atherosclerosis, neurodegeneration and tumour growth. Evidence suggests that the protective effect of exercise may to some extent be ascribed to the anti‐inflammatory effect of regular exercise, which can be mediated via a reduction in visceral fat mass and/or by induction of an anti‐inflammatory environment with each bout of exercise. The finding that muscles produce and release myokines provides a conceptual basis to understand the mechanisms whereby exercise influences metabolism and exerts anti‐inflammatory effects. According to our theory, contracting skeletal muscles release myokines, which work in a hormone‐like fashion, exerting specific endocrine effects on visceral fat. Other myokines work locally within the muscle via paracrine mechanisms, exerting their effects on signalling pathways involved in fat oxidation.

[1]  M. Ståhlberg,et al.  Activation of the erythropoietin receptor in human skeletal muscle. , 2009, European journal of endocrinology.

[2]  E. L. Mortensen,et al.  Brain‐Derived Neurotrophic Factor Predicts Mortality Risk in Older Women , 2009, Journal of the American Geriatrics Society.

[3]  J. Gehl,et al.  Erythropoietin Over-Expression Protects against Diet-Induced Obesity in Mice through Increased Fat Oxidation in Muscles , 2009, PloS one.

[4]  M. Febbraio,et al.  Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase , 2009, Diabetologia.

[5]  Mark A. Smith,et al.  Central obesity and increased risk of dementia more than three decades later. , 2009, Neurology.

[6]  G. Colditz,et al.  Physical activity and colon cancer prevention: a meta-analysis , 2009, British Journal of Cancer.

[7]  K. Walsh,et al.  Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent Mechanism* , 2008, Journal of Biological Chemistry.

[8]  M. Schulze,et al.  General and abdominal adiposity and risk of death in Europe. , 2008, The New England journal of medicine.

[9]  Yuichi Akasaki,et al.  FGF21 is an Akt‐regulated myokine , 2008, FEBS letters.

[10]  Tuomo Hänninen,et al.  BDNF is a novel marker of cognitive function in ageing women: The DR’s EXTRA Study , 2008, Neurobiology of Learning and Memory.

[11]  J. Gehl,et al.  Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass. , 2008, The Journal of clinical endocrinology and metabolism.

[12]  M. Febbraio,et al.  Muscle as an endocrine organ: focus on muscle-derived interleukin-6. , 2008, Physiological reviews.

[13]  E. Barrett-Connor,et al.  Central obesity and increased risk of dementia more than three decades later , 2008, Neurology.

[14]  Christoph Handschin,et al.  The role of exercise and PGC1α in inflammation and chronic disease , 2008, Nature.

[15]  S. Kalra,et al.  METABOLIC RESPONSES TO REDUCED DAILY STEPS IN HEALTHY NONEXERCISING MEN , 2008 .

[16]  S. Willich,et al.  Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[17]  B. Pedersen,et al.  Exercise induces expression of leukaemia inhibitory factor in human skeletal muscle , 2008, The Journal of physiology.

[18]  B. Pedersen,et al.  Metabolic responses to reduced daily steps in healthy nonexercising men. , 2008, JAMA.

[19]  B. Pedersen,et al.  Tumor Necrosis Factor-α Modulates Human in Vivo Lipolysis , 2008 .

[20]  B. Göke,et al.  Type 2 diabetes mellitus as risk factor for colorectal cancer , 2008, Archives of physiology and biochemistry.

[21]  J. Yudkin,et al.  Inflammation, Obesity, and the Metabolic Syndrome , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[22]  B. Pedersen,et al.  Expression of interleukin‐15 in human skeletal muscle – effect of exercise and muscle fibre type composition , 2007, The Journal of physiology.

[23]  S. Haffner Abdominal adiposity and cardiometabolic risk: do we have all the answers? , 2007, The American journal of medicine.

[24]  K. Michels,et al.  Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. , 2007, The American journal of clinical nutrition.

[25]  E. Giovannucci Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. , 2007, The American journal of clinical nutrition.

[26]  B. Pedersen,et al.  The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[27]  A. Barabasi,et al.  Network medicine--from obesity to the "diseasome". , 2007, The New England journal of medicine.

[28]  B. Pedersen,et al.  Body mass index‐independent effect of fitness and physical activity for all‐cause mortality , 2007, Scandinavian journal of medicine & science in sports.

[29]  Wan-Wan Lin,et al.  A cytokine-mediated link between innate immunity, inflammation, and cancer. , 2007, The Journal of clinical investigation.

[30]  C. Matter,et al.  RANTES (regulated on activation, normal T cell expressed and secreted), inflammation, obesity, and the metabolic syndrome. , 2007, Circulation.

[31]  Colm Cunningham,et al.  Systemic infections and inflammation affect chronic neurodegeneration , 2007, Nature Reviews Immunology.

[32]  N. Secher,et al.  Brain-derived neurotrophic factor (BDNF) and type 2 diabetes , 2007, Diabetologia.

[33]  D. Voskuil,et al.  Physical Activity and Breast Cancer: A Systematic Review , 2007, Epidemiology.

[34]  B. Pedersen,et al.  Plasma levels of interleukin‐6 and C‐reactive protein are associated with physical inactivity independent of obesity , 2006, Scandinavian journal of medicine & science in sports.

[35]  Frauke Zipp,et al.  The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases , 2006, Trends in Neurosciences.

[36]  M. Bartels,et al.  Stage-dependent BDNF serum concentrations in Alzheimer’s disease , 2006, Journal of Neural Transmission.

[37]  M. Diamant,et al.  The metabolic syndrome and endothelial dysfunction: Common highway to type 2 diabetes and CVD? , 2006, Current diabetes reports.

[38]  P. Gallagher,et al.  Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. , 2005, International journal of cardiology.

[39]  B. Winblad,et al.  Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease , 2005, The Lancet Neurology.

[40]  B. Pedersen,et al.  TNF-α, but not IL-6, stimulates plasminogen activator inhibitor-1 expression in human subcutaneous adipose tissue , 2005 .

[41]  C. Stehouwer,et al.  “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease , 2005, The Lancet.

[42]  Bente Klarlund Pedersen,et al.  The anti-inflammatory effect of exercise. , 2005, Journal of applied physiology.

[43]  Stuart Maudsley,et al.  BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders , 2004, Trends in Neurosciences.

[44]  G. Hotamisligil,et al.  Inflammatory pathways and insulin action , 2003, International Journal of Obesity.

[45]  B. Saltin,et al.  Interleukin-6 stimulates lipolysis and fat oxidation in humans. , 2003, The Journal of clinical endocrinology and metabolism.

[46]  Bente Klarlund Pedersen,et al.  Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  W. Tyler,et al.  From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. , 2002, Learning & memory.

[48]  S. Haffner,et al.  Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2002, Diabetes.

[49]  J. Aubry,et al.  Decreased serum brain-derived neurotrophic factor levels in major depressed patients , 2002, Psychiatry Research.

[50]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[51]  Y Itakura,et al.  Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. , 2000, Diabetes.

[52]  G. Yancopoulos,et al.  Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. , 1999, Diabetes.

[53]  R. Faull,et al.  Brain-derived neurotrophic factor is reduced in Alzheimer's disease. , 1997, Brain research. Molecular brain research.

[54]  Y Itakura,et al.  Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. , 1997, Biochemical and biophysical research communications.

[55]  R. Paffenbarger,et al.  Physical activity and personal characteristics associated with depression and suicide in American college men , 1994, Acta psychiatrica Scandinavica. Supplementum.

[56]  J. Argilés,et al.  Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. , 2009, American journal of physiology. Endocrinology and metabolism.

[57]  H. Bays "Sick fat," metabolic disease, and atherosclerosis. , 2009, The American journal of medicine.

[58]  J. Gehl,et al.  Association between IL-15 and obesity: IL-15 as a potential regulator of fat mass , 2008 .

[59]  N. Christakis,et al.  SUPPLEMENTARY ONLINE MATERIAL FOR: THE SPREAD OF OBESITY IN A LARGE SOCIAL NETWORK OVER 32 YEARS , 2007 .

[60]  M. Febbraio,et al.  Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. , 2005, American journal of physiology. Endocrinology and metabolism.

[61]  L. Pollack,et al.  Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer , 2005, Nature Clinical Practice Oncology.

[62]  D. Nieman Current perspective on exercise immunology , 2003, Current sports medicine reports.

[63]  C. Ohlsson,et al.  Interleukin-6-deficient mice develop mature-onset obesity , 2002, Nature Medicine.